» Articles » PMID: 31733439

Generation of Fibrodysplasia Ossificans Progressiva and Control Integration Free IPSC Lines from Periodontal Ligament Fibroblasts

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2019 Nov 17
PMID 31733439
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrodysplasia ossificans progressiva (FOP) is a very rare devastating heterotopic ossification disorder, classically caused by a heterozygous single point mutation (c.617G>A) in the ACVR1gene, encoding the Bone morphogenetic protein (BMP) type I receptor, also termed activin receptor-like kinase (ALK)2. FOP patients develop heterotopic ossification episodically in response to inflammatory insults, thereby compromising tissue sampling and the development of in vitro surrogate models for FOP. Here we describe the generation and characterization of a control and a classical FOP induced pluripotent stem cell (iPSC) line derived from periodontal ligament fibroblast cells using Sendai virus vectors.

Citing Articles

Human iPSCs as Model Systems for BMP-Related Rare Diseases.

Sanchez-Duffhues G, Hiepen C Cells. 2023; 12(17).

PMID: 37681932 PMC: 10487005. DOI: 10.3390/cells12172200.


Enhancer hijacking at the ARHGAP36 locus is associated with connective tissue to bone transformation.

Melo U, Jatzlau J, Prada-Medina C, Flex E, Hartmann S, Ali S Nat Commun. 2023; 14(1):2034.

PMID: 37041138 PMC: 10090176. DOI: 10.1038/s41467-023-37585-8.


Stem Cells and Their Derivatives-Implications for Alveolar Bone Regeneration: A Comprehensive Review.

Holly D, Klein M, Mazreku M, Zamborsky R, Polak S, Danisovic L Int J Mol Sci. 2021; 22(21).

PMID: 34769175 PMC: 8583713. DOI: 10.3390/ijms222111746.


Although Anatomically Micrometers Apart: Human Periodontal Ligament Cells Are Slightly More Active in Bone Remodeling Than Alveolar Bone Derived Cells.

Loo-Kirana R, Gilijamse M, Hogervorst J, Schoenmaker T, de Vries T Front Cell Dev Biol. 2021; 9:709408.

PMID: 34616725 PMC: 8488427. DOI: 10.3389/fcell.2021.709408.


Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva.

Ventura F, Williams E, Ikeya M, Bullock A, Ten Dijke P, Goumans M Biomedicines. 2021; 9(2).

PMID: 33669809 PMC: 7922784. DOI: 10.3390/biomedicines9020213.